# Iovance Biotherapeutics, Inc.: Form 8-K, filed Feb 10, 2025

- Company: [Iovance Biotherapeutics, Inc.](/companies/iova.md) (CIK 1425205)
- Form: 8-K
- Filed: 2025-02-10
- Accepted by EDGAR: Feb 10, 2025, 07:22 ET
- Period: 2025-02-10
- Accession: 0001104659-25-010729
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1425205/000110465925010729/tm255949d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1425205/000110465925010729/

## Items reported

- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1425205/000110465925010729/tm255949d1_8k.htm

Filed Feb 10, 2025.
Source: SEC EDGAR, the filing index for accession 0001104659-25-010729. Last ingested by Listed: Nov 5, 2026, 19:56 ET. No prices; not investment advice.